A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

Title
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
Authors
Keywords
Neoadjuvant chemotherapy, Advanced gastric cancer, Docetaxel, Oxaliplatin, S-1
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 72, Issue 4, Pages 815-823
Publisher
Springer Nature
Online
2013-08-06
DOI
10.1007/s00280-013-2257-z

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now